IDYA
IDEAYA Biosciences·NASDAQ
--
--(--)
--
--(--)
4.55 / 10
Netural
Fund flow metrics score 7.5/10, reflecting robust capital inflows, particularly in block and extra-large transactions. Analyst sentiment is generally bullish with 66.7% Strong Buy and 33.3% Buy ratings, though historical win rates vary significantly by institution, adding uncertainty.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-06
InstitutionTruist Securities
Times predicted2
Historical Win Rate0.0%
What is the market sentiment for IDYA?
- IDYA holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.55/10 (Netural).
